Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Diabetol Metab Syndr ; 15(1): 162, 2023 Jul 22.
Article in English | MEDLINE | ID: mdl-37481586

ABSTRACT

BACKGROUND: Patients with diabetes mellitus (DM) have cardiovascular diseases (CVD) as a major cause of mortality and morbidity. The primary purpose of this study was to assess the echocardiographic parameters that showed alterations in patients with type 2 diabetes mellitus(T2DM) with suggestive coronary artery disease (CAD) determined by electrocardiography and the secondary was to assess the relationship of these alterations with established cardiovascular risk factors. METHODS: This cross-sectional, observational pilot study included 152 consecutive patients with T2DM who attended a tertiary DM outpatient care center. All patients underwent clinical examination and history, anthropometric measurements, demographic survey, determination of the Framingham global risk score, laboratory evaluation, basal electrocardiogram, echocardiogram, and measurement of carotid intima-media thickness (CIMT). RESULTS: From the overall sample, 134 (88.1%) patients underwent an electrocardiogram. They were divided into two groups: patients with electrocardiograms suggestive of CAD (n = 11 [8.2%]) and those with normal or non-ischemic alterations on electrocardiogram (n = 123 [91.79%]). In the hierarchical multivariable logistic model examining all selected independent factors that entered into the model, sex, high triglycerides levels, and presence of diabetic retinopathy were associated with CAD in the final model. No echocardiographic parameters were significant in multivariate analysis. The level of serum triglycerides (threshold) related to an increased risk of CAD was ≥ 184.5 mg/dl (AUC = 0.70, 95% IC [0.51-0.890]; p = 0.026. CONCLUSION: Our pilot study demonstrated that no echocardiogram parameters could predict or determine CAD. The combination of CIMT and Framingham risk score is ideal to determine risk factors in asymptomatic patients with T2DM. Patients with diabetic retinopathy and hypertriglyceridemia need further investigation for CAD. Further prospective studies with larger sample sizes are needed to confirm our results.

2.
Int J Cardiol ; 107(3): 307-16, 2006 Mar 08.
Article in English | MEDLINE | ID: mdl-15919123

ABSTRACT

The frequency domain analysis of the P-wave signal-averaged ECG (P-SAECG) is able to identify patients at risk for lone atrial fibrillation (AF) after cardioversion to sinus rhythm. The terminal portion of the P-wave of right precordial leads on 12-lead ECG is associated with electrical abnormalities in the atria. The aim of this study was to assess the spectral turbulence analysis (STA) of the P-SAECG as a predictor of recurrence of idiopathic AF. STA was performed in 41 patients with 2 or more symptomatic episodes of idiopathic and persistent AF after successful electrical cardioversion and drug-free state (Group A), and in 25 control individuals during sinus rhythm (Group B), matched by age, gender, and P-wave duration. The orientation of the terminal portion (positive or negative) of the Z-lead was assessed as representing right precordial leads potentials. After 6 months follow-up, Group A was divided into two groups according to recurrence: G-A1--at least one recurrence (21 patients), and G-A2--no recurrence (20 patients). Fragmented electrical activity (FEA) was observed in 19 patients of G-A1 and in 2 of G-A2 (odds ratio = 85.5; p<<0.001). STA showed 90.5% sensitivity and 90.0% specificity for early recurrence of AF. After 12 months, no patients of G-A2 and 15 of G-A1 developed >3 episodes of persistent AF, being FEA observed in 13 (odds ratio = 14.6, p = 0.002). No episodes of AF were observed in Group B. Average time for recurrence of FEA positive patients (4.3 +/- 0.7 months) was significantly shorter than of G-A2 (7.4+/-0.7 months), and log-rank analysis revealed significant difference of event-free rate over time (p = 0.004). In a logistic regression model FEA, use of amiodarone and a positive terminal portion of the Z-lead of the P-SAECG were independent predictors of recurrence of idiopathic and persistent AF.


Subject(s)
Atrial Fibrillation/diagnosis , Electrocardiography , Signal Processing, Computer-Assisted , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Case-Control Studies , Female , Humans , Male , Matched-Pair Analysis , Middle Aged , Predictive Value of Tests , Recurrence , Retrospective Studies , Survival Analysis
3.
Int J Cardiol ; 101(2): 237-42, 2005 May 25.
Article in English | MEDLINE | ID: mdl-15882670

ABSTRACT

BACKGROUND: Early angiotensin-converting enzyme (ACE) inhibition is able to re-program spontaneously hypertensive rats (SHR) to express an attenuated form of disease in adulthood. METHODS: Three groups of animals (n=5 each) were studied: Wistar male rats, SHR males, and SHR males obtained from dams treated with enalapril maleate (15 mg/kg/day) during gestation. Animals were sacrificed 180 days after birth, and hearts were removed for stereological quantification. Volume [Vv] (myocytes, cardiac interstitium and intramyocardial vessels), length [Lv] (intramyocardial vessels), surface [Sv] densities (myocyte and intramyocardial vessels), and the mean cross-sectional area [a] (myocyte) were estimated. RESULTS: Blood pressure (BP) was lower in Wistar group, higher in SHR group, and intermediate in SHR-enalapril group (respectively: 122+/-8.4, 194+/-11.4, and 158+/-7.6 mm Hg, p<0.0001). Increased Vv (p=0.016), Lv (p<0.01), and Sv (p<0.01) of intramyocardial vessels were observed in SHR-enalapril group when compared to untreated SHR. A small but significant reduction was observed in a of myocytes (p=0.045). CONCLUSION: Prenatal ACE inhibition resulted in partial hypertension attenuation as well as left ventricular hypertrophy (LVH). The positive impact on the vascular compartment came along with little or no difference in myocytes and interstitium, suggesting the involvement of a direct mechanism.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Coronary Vessels/drug effects , Enalapril/administration & dosage , Hypertension/prevention & control , Animals , Female , Heart Ventricles/drug effects , Heart Ventricles/pathology , Male , Microcirculation/drug effects , Pregnancy , Prenatal Care , Rats , Rats, Inbred SHR , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...